94 related articles for article (PubMed ID: 27760326)
1. Non-oncogenic Acute Viral Infections Disrupt Anti-cancer Responses and Lead to Accelerated Cancer-Specific Host Death.
Kohlhapp FJ; Huelsmann EJ; Lacek AT; Schenkel JM; Lusciks J; Broucek JR; Goldufsky JW; Hughes T; Zayas JP; Dolubizno H; Sowell RT; Kühner R; Burd S; Kubasiak JC; Nabatiyan A; Marshall S; Bommareddy PK; Li S; Newman JH; Monken CE; Shafikhani SH; Marzo AL; Guevara-Patino JA; Lasfar A; Thomas PG; Lattime EC; Kaufman HL; Zloza A
Cell Rep; 2016 Oct; 17(4):957-965. PubMed ID: 27760326
[TBL] [Abstract][Full Text] [Related]
2. Immunobiochemical Reconstruction of Influenza Lung Infection-Melanoma Skin Cancer Interactions.
Nikolaev EV; Zloza A; Sontag ED
Front Immunol; 2019; 10():4. PubMed ID: 30745900
[TBL] [Abstract][Full Text] [Related]
3. The PD-1 Pathway Regulates Development and Function of Memory CD8
Pauken KE; Godec J; Odorizzi PM; Brown KE; Yates KB; Ngiow SF; Burke KP; Maleri S; Grande SM; Francisco LM; Ali MA; Imam S; Freeman GJ; Haining WN; Wherry EJ; Sharpe AH
Cell Rep; 2020 Jun; 31(13):107827. PubMed ID: 32610128
[TBL] [Abstract][Full Text] [Related]
4. Acute Viral Respiratory Infection Rapidly Induces a CD8+ T Cell Exhaustion-like Phenotype.
Erickson JJ; Lu P; Wen S; Hastings AK; Gilchuk P; Joyce S; Shyr Y; Williams JV
J Immunol; 2015 Nov; 195(9):4319-30. PubMed ID: 26401005
[TBL] [Abstract][Full Text] [Related]
5. PD-1 blockade induces responses by inhibiting adaptive immune resistance.
Tumeh PC; Harview CL; Yearley JH; Shintaku IP; Taylor EJ; Robert L; Chmielowski B; Spasic M; Henry G; Ciobanu V; West AN; Carmona M; Kivork C; Seja E; Cherry G; Gutierrez AJ; Grogan TR; Mateus C; Tomasic G; Glaspy JA; Emerson RO; Robins H; Pierce RH; Elashoff DA; Robert C; Ribas A
Nature; 2014 Nov; 515(7528):568-71. PubMed ID: 25428505
[TBL] [Abstract][Full Text] [Related]
6. TIGIT and PD-1 impair tumor antigen-specific CD8⁺ T cells in melanoma patients.
Chauvin JM; Pagliano O; Fourcade J; Sun Z; Wang H; Sander C; Kirkwood JM; Chen TH; Maurer M; Korman AJ; Zarour HM
J Clin Invest; 2015 May; 125(5):2046-58. PubMed ID: 25866972
[TBL] [Abstract][Full Text] [Related]
7. Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia.
Paget C; Ivanov S; Fontaine J; Blanc F; Pichavant M; Renneson J; Bialecki E; Pothlichet J; Vendeville C; Barba-Spaeth G; Huerre MR; Faveeuw C; Si-Tahar M; Trottein F
J Immunol; 2011 May; 186(10):5590-602. PubMed ID: 21490153
[TBL] [Abstract][Full Text] [Related]
8. IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells.
Sun Z; Fourcade J; Pagliano O; Chauvin JM; Sander C; Kirkwood JM; Zarour HM
Cancer Res; 2015 Apr; 75(8):1635-44. PubMed ID: 25720800
[TBL] [Abstract][Full Text] [Related]
9. Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.
Wen SC; Schuster JE; Gilchuk P; Boyd KL; Joyce S; Williams JV
J Virol; 2015 Sep; 89(17):8713-26. PubMed ID: 26063431
[TBL] [Abstract][Full Text] [Related]
10. Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 through Enhanced Antitumor T-cell Responses.
Beavis PA; Milenkovski N; Henderson MA; John LB; Allard B; Loi S; Kershaw MH; Stagg J; Darcy PK
Cancer Immunol Res; 2015 May; 3(5):506-17. PubMed ID: 25672397
[TBL] [Abstract][Full Text] [Related]
11. Critical role of natural killer cells in lung immunopathology during influenza infection in mice.
Abdul-Careem MF; Mian MF; Yue G; Gillgrass A; Chenoweth MJ; Barra NG; Chew MV; Chan T; Al-Garawi AA; Jordana M; Ashkar AA
J Infect Dis; 2012 Jul; 206(2):167-77. PubMed ID: 22561366
[TBL] [Abstract][Full Text] [Related]
12. The Flavonoid Isoliquiritigenin Reduces Lung Inflammation and Mouse Morbidity during Influenza Virus Infection.
Traboulsi H; Cloutier A; Boyapelly K; Bonin MA; Marsault É; Cantin AM; Richter MV
Antimicrob Agents Chemother; 2015 Oct; 59(10):6317-27. PubMed ID: 26248373
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral injection of IFN-β induces chemokine production in melanoma and augments the therapeutic efficacy of anti-PD-L1 mAb.
Uehara J; Ohkuri T; Kosaka A; Ishibashi K; Hirata Y; Ohara K; Nagato T; Oikawa K; Aoki N; Harabuchi Y; Ishida-Yamamoto A; Kobayashi H
Biochem Biophys Res Commun; 2017 Aug; 490(2):521-527. PubMed ID: 28624449
[TBL] [Abstract][Full Text] [Related]
14. Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication.
Hastings AK; Erickson JJ; Schuster JE; Boyd KL; Tollefson SJ; Johnson M; Gilchuk P; Joyce S; Williams JV
J Virol; 2015 Apr; 89(8):4405-20. PubMed ID: 25653440
[TBL] [Abstract][Full Text] [Related]
15. Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor--secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors.
Li B; VanRoey M; Wang C; Chen TH; Korman A; Jooss K
Clin Cancer Res; 2009 Mar; 15(5):1623-34. PubMed ID: 19208793
[TBL] [Abstract][Full Text] [Related]
16. Immune checkpoints and their inhibition in cancer and infectious diseases.
Dyck L; Mills KHG
Eur J Immunol; 2017 May; 47(5):765-779. PubMed ID: 28393361
[TBL] [Abstract][Full Text] [Related]
17. Premature terminal exhaustion of Friend virus-specific effector CD8+ T cells by rapid induction of multiple inhibitory receptors.
Takamura S; Tsuji-Kawahara S; Yagita H; Akiba H; Sakamoto M; Chikaishi T; Kato M; Miyazawa M
J Immunol; 2010 May; 184(9):4696-707. PubMed ID: 20351188
[TBL] [Abstract][Full Text] [Related]
18. Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic options.
Velu V; Shetty RD; Larsson M; Shankar EM
Retrovirology; 2015 Feb; 12():14. PubMed ID: 25756928
[TBL] [Abstract][Full Text] [Related]
19. PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell Killing.
Akhmetzyanova I; Drabczyk M; Neff CP; Gibbert K; Dietze KK; Werner T; Liu J; Chen L; Lang KS; Palmer BE; Dittmer U; Zelinskyy G
PLoS Pathog; 2015 Oct; 11(10):e1005224. PubMed ID: 26484769
[TBL] [Abstract][Full Text] [Related]
20. Identification and Characterization of MEDI4736, an Antagonistic Anti-PD-L1 Monoclonal Antibody.
Stewart R; Morrow M; Hammond SA; Mulgrew K; Marcus D; Poon E; Watkins A; Mullins S; Chodorge M; Andrews J; Bannister D; Dick E; Crawford N; Parmentier J; Alimzhanov M; Babcook JS; Foltz IN; Buchanan A; Bedian V; Wilkinson RW; McCourt M
Cancer Immunol Res; 2015 Sep; 3(9):1052-62. PubMed ID: 25943534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
